Status:
UNKNOWN
Home Management of Adult Egyptian Mild COVID-19 Cases
Lead Sponsor:
Cairo University
Conditions:
Covid19
Telemedicine
Eligibility:
All Genders
18-65 years
Brief Summary
Keeping in mind the rising number of cases in Egypt and the strain they put on hospital infrastructure, the idea of home isolation and follow up for COVID 19 positive cases has been adopted in many co...
Detailed Description
Objectives: * To assess the effectiveness of follow up of mild COVID-19 cases in home isolation * To assess the applicability of telemedicine tools in the follow up of those patients and early identi...
Eligibility Criteria
Inclusion
- No co-morbidities that necessitates hospital admission due to high risk for progression of the disease: Pregnancy, uncontrolled Diabetes, Chronic lung disease, Chronic kidney disease, Chronic liver disease, Serious heart diseases (arrythmia, Ischemic heart disease, uncontrolled hypertension), immunocompromised: prolonged use of corticosteroids and other immunosuppressive drugs/ organ transplantation/ HIV/ Immunodeficiency.
- No fever (oral, below or equal 37.50 C )
- No shortness of breath (Respiratory rate 12-20/min)
- Oxygen saturation \>= 96 %
- CT chest: Normal
- Labs: D-dimer\<1000ng/ml, CPK\< twice upper limit of normal, CRP\<100, LDH\<245, Ferritin\<500, absolute lymphocytic count \>0.8
Exclusion
- Moderate and severe cases not fulfilling the definition of mild cases.
- Children and young \< 18 years.
- Age \>65 years.
- Presence of any of the previously mentioned comorbidities.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04515199
Start Date
July 1 2020
End Date
March 1 2021
Last Update
August 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Cairo University
Cairo, Egypt